Kevin Van der Jeught
10PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Nov 02, 2021
An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity.Zhuolong Zhou, Kevin Van der Jeught, Yuanzhang Fang
|Feb 11, 2021
Targeted immunotherapy for HER2-low breast cancer with 17p loss.Yujing Li, Yifan Sun, Michael Kulke
|Jan 19, 2020
Author Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer.Jiangsheng Xu, Yunhua Liu, Yujing Li
|Mar 07, 2019
Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer.Jiangsheng Xu, Yunhua Liu, Yujing Li
|Feb 27, 2019
Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer.Jiangsheng Xu, Yunhua Liu, Yujing Li
|Nov 11, 2018
Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer.Yunhua Liu, Jiangsheng Xu, Hyun Ho Choi
Pageof 2